Fluorouracil, Cisplatin, and Radiation Therapy or Gemcitabine and Oxaliplatin in Treating Patients With Nonmetastatic Biliary Tract Cancer That Cannot Be Removed By Surgery

PHASE2/PHASE3CompletedINTERVENTIONAL
Enrollment

34

Participants

Timeline

Start Date

October 31, 2005

Primary Completion Date

December 31, 2012

Study Completion Date

December 31, 2012

Conditions
Extrahepatic Bile Duct CancerGallbladder CancerLiver Cancer
Interventions
DRUG

cisplatin

DRUG

gemcitabine hydrochloride

DRUG

oxaliplatin

Trial Locations (20)

13385

CHU de la Timone, Marseille

21034

Hopital Du Bocage, Dijon

21079

Centre de Lutte Contre le Cancer Georges-Francois Leclerc, Dijon

21140

Centre Hospitalier de Semur en Auxois, Semur-en-Auxois

35062

Centre Eugene Marquis, Rennes

38300

Centre Hospitalier Pierre Oudot, Bourgoin

40000

Centre Hospitalier General de Mont de Marsan, Mont-de-Marsan

40100

Centre Hospitalier de Dax, Dax

45100

CHR D'Orleans - Hopital de la Source, Orléans

51092

Hopital Sebastopol, C.H.U. de Reims, Reims

65013

Centre Hospitalier de Tarbes, Tarbes

67098

Hopital Universitaire Hautepierre, Strasbourg

68024

Hopital Louis Pasteur, Colmar

69495

Centre Hospitalier Lyon Sud, Pierre-Bénite

72037

C. H. Du Mans, Le Mans

75018

Hopital Bichat - Claude Bernard, Paris

75651

CHU Pitie-Salpetriere, Paris

76031

Hopital Charles Nicolle, Rouen

90000

Centre Hospitalier General, Belfort

F-85025

Centre Hospitalier Departemental, La Roche-sur-Yon

All Listed Sponsors
lead

Federation Francophone de Cancerologie Digestive

OTHER

NCT00304135 - Fluorouracil, Cisplatin, and Radiation Therapy or Gemcitabine and Oxaliplatin in Treating Patients With Nonmetastatic Biliary Tract Cancer That Cannot Be Removed By Surgery | Biotech Hunter | Biotech Hunter